Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
100 Billion Live Probiotics in a Bottle: TCI JAPAN Launched its Breakthrough, SCIENCE OF PROBIOTICS, After 20 Years of Research 2021-06-23 14:28
Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars 2021-06-23 04:16
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia 2021-06-22 22:32
Bioheng Biotech received Orphan Drug Designation from the U.S. FDA for the treatment of T-ALL. 2021-06-20 21:00
InnoCare Presents Latest Clinical Data of Orelabrutinib at the16th International Conference on Malignant Lymphoma 2021-06-18 17:12
Harbour BioMed Announces Dosing of First Patient of Next-Generation Anti-CTLA-4 Antibody in Combination with PD-1 Antibody in Patients with NSCLC 2021-06-17 15:41
InnoCare Announces Orphan Drug Designation of Gunagrabtinib by US FDA for Treatment of Cholangiocarcinoma 2021-06-17 11:31
Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment 2021-06-16 13:08
Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci 2021-06-16 10:14
BIO Digital Taiwan Day will be held on June 22 2021-06-15 23:00
The U.S. FDA Approved IND Application to Investigate Combination of Asieris' APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients 2021-06-15 08:46
Happiness Biotech Signed Agreement To Distribute Volkswagen Electric Vehicles 2021-06-14 20:00
Bridge Biotherapeutics Announces the Initiation of Patient Dosing in the Proof of Clinical Principle Study for BBT-401, an Investigational Drug for Ulcerative Colitis 2021-06-14 06:00
OliPass Expands Scientific Advisory Board by Inviting Experts in Pain To Bolster Phase 2 Clinical Trial Design and Management 2021-06-10 21:00
Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer 2021-06-09 21:00
Cell Care Joins the Generate Life Sciences Family to Create a Global Platform 2021-06-03 06:00
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement 2021-06-02 21:00
Portonbio announced strategic cooperation with KAEDI to accelerate the R&D and production of CAR-T drugs 2021-06-02 20:10
PharmAbcine to Present at the BIO Digital International Convention 2021 2021-06-02 20:00
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate 2021-06-02 19:00
1 143 144 145 146 147 260